The primary objective of our centre is to translate recent huge advances in the basic understanding of the pathogenesis of coeliac disease to the clinic – to improve disease diagnostics, to implement novel treatments and to identify new therapeutic targets for this common disease.
The secondary objective is to become a clinical research site at the international forefront which will provide optimal patient care and which will be a unique training site for basic scientists and clinicians.
What's really behind 'gluten sensitivity'? Story in Science about our research
May 24, 2018 10:52 AM
The patients weren't crazy—Knut Lundin was sure of that. But their ailment was a mystery. They were convinced gluten was making them sick. Yet they didn't have celiac disease, an autoimmune reaction to that often-villainized tangle of proteins in wheat, barley, and rye. And they tested negative for a wheat allergy. They occupied a medical no man's land. (Servick, Science News, 2018)
"Do blood tests before starting gluten-free diet". Knut Lundin in Maltese newspaper on the International Coeliac Day
May 18, 2018 1:00 PM
Gastroenterologist and J CoDiRC group leader Knut Lundin is the keynote speaker at the National Coeliac Conference 2018, UK. The conference is arranged in Malta by Coeliac UK and Narrative Structures to increase awareness of coeliac disease.
- Disease-driving CD4+ T cell clonotypes persist for decades in celiac disease May 15, 2018 11:00 AM
- Pharmacomicrobiomics: a novel route towards personalized medicine? May 1, 2018 11:00 AM
- Characterization of the Small Intestinal Lesion in Celiac Disease by Label-Free Quantitative Mass Spectrometry Apr. 24, 2018 11:00 AM